PCa17: Young urologists appreciate point-by-point discussions

15 September 2017

doctors-hernandez-and-mohammed-cropped-aa

Point-by-point discussions and practical insights on key treatment and management strategies in prostate cancer have impressed young urologists who are participating at the two-day EAU Update on Prostate Cancer (PCa17) in Vienna.

PCa17, the first in a planned series of updates on onco-urological diseases, opened today with two plenary sessions that preceded breakout case discussions to enable both faculty and participants to directly interact and take more time in examining dilemmas and clinical challenges in managing prostate cancer.

“I haven’t been to previous EAU meetings, so this is my first. I welcomed the idea of an interactive meeting. The lectures were to the point and the messages were clear. The discussions also were very good since it pushes you to think critically on standard practices,” said Dr. Saif Mohammed (Baghdad, Iraq).

“My expectations are to learn the major treatment approaches. Frankly speaking, many of the tools and technologies mentioned during the lectures such as MRI or Diffusion Weighted Imaging are not available in my country. But I look for key points which I can use in actual clinical practice or share with my colleagues back home,” added Mohammed.

Dr. Yomaida Hernandez (Spain) took note of the faculty members which she said are internationally known for their expertise and experience.

“It is good to attend a meeting where you can directly ask an expert since you can pick up important insights,” said Hernandez who specialized in urology three years ago. She added that formats such as the breakout sessions used in the meeting are ideal since questions from the participants are not only encouraged but also assessed by the resource speakers.

“In the case discussions we have to select the best answer and these are reflected on-screen as total votes. But what is informative is the comment or remarks of the expert professors regarding the basis or objective of the most correct answer. I have learned or have expanded my perspective after these case discussions,” added Hernandez.

The second plenary session focused on local treatments with Professors Francesco Montorsi (Italy) examining the role of radical prostatectomy, Peter Hoskin providing a practical overview on radiotherapy and brachytherapy, and Alberto Briganti looking into salvage focal treatment for recurrent disease.

Some of their key messages were:

  • “Radical prostatectomy (RP) plays a major role in intermediate and high-risk patients. Surgery should be considered in a multi-modal setting with or without immediate postoperative RT.” (Montorsi).
  • “Do not treat with ADT, men potentially suitable for salvage curative treatment. Salvage local treatment represents a valid option for recurring men with presumed or documented local failure in the absence of distant metastases.” (Briganti)
  • Brachytherapy has a role in all risk groups of prostate cancer whether low to intermediate-risk patients who will be treated with brachytherapy alone or those with high-risk disease who will benefit from added brachytherapy or external beam.” (Hoskins)